Trial Profile
Use of Bemiparine as a Prophylactic Antitrombotic Agent, in Patients Undergoing Microsurgery for Head and Neck Reconstruction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Feb 2019
Price :
$35
*
At a glance
- Drugs Bemiparin sodium (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis
- Focus Adverse reactions
- 15 Feb 2019 Status changed from recruiting to completed.
- 05 Jul 2016 New trial record